HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
I Virgolini Selected Research
I Virgolini Research Topics
Disease
13
Neoplasms (Cancer)
01/2014 - 03/2000
4
Thyroid Neoplasms (Thyroid Cancer)
04/2019 - 01/2002
4
Neoplasm Metastasis (Metastasis)
02/2010 - 12/2000
4
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2002 - 01/2001
3
Lymphoma (Lymphomas)
01/2012 - 09/2001
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2002 - 06/2001
2
Adenocarcinoma
02/2002 - 03/2001
2
Carcinoma (Carcinomatosis)
02/2002 - 02/2001
2
Lung Neoplasms (Lung Cancer)
01/2002 - 09/2001
2
Liver Neoplasms (Liver Cancer)
01/2002 - 06/2000
1
Squamous Cell Carcinoma of Head and Neck
12/2012
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012
1
Hodgkin Disease (Hodgkin's Disease)
01/2012
1
Nausea
02/2002
1
Weight Gain
02/2002
1
Pancreatic Neoplasms (Pancreatic Cancer)
12/2001
1
Familial primary gastric lymphoma
11/2001
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
11/2001
1
Burkitt Lymphoma (Burkitt's Lymphoma)
05/2001
1
Colorectal Neoplasms (Colorectal Cancer)
03/2001
1
Disease Progression
06/2000
1
Carcinoid Tumor (Carcinoid)
03/2000
Drug/Important Bio-Agent (IBA)
9
Somatostatin Receptors (Somatostatin Receptor)
IBA
01/2014 - 06/2001
8
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2014 - 03/2000
7
lanreotide (Somatuline)
FDA Link
02/2002 - 03/2000
5
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
IBA
02/2010 - 03/2000
4
Peptides (Polypeptides)
IBA
01/2014 - 03/2000
4
Radioisotopes (Radionuclides)
IBA
07/2011 - 01/2001
3
Peptide Receptors (Peptide Receptor)
IBA
07/2011 - 03/2000
3
Octreotide (Sandostatin)
FDA Link
Generic
01/2002 - 03/2000
3
indium 111-DOTA-lanreotide
IBA
09/2001 - 01/2001
2
Radiopharmaceuticals
IBA
04/2019 - 03/2000
2
Glucose (Dextrose)
FDA Link
Generic
01/2012 - 12/2000
2
Acids
IBA
12/2001 - 09/2001
2
Ligands
IBA
12/2001 - 05/2001
2
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
03/2001 - 02/2001
1
Iodine
IBA
01/2015
1
somatostatin receptor 2
IBA
01/2014
1
somatostatin receptor 5
IBA
12/2012
1
Chromogranin A
IBA
12/2012
1
Synaptophysin
IBA
12/2012
1
Fluorine
IBA
01/2012
1
gallium 68-DOTA-lanreotide
IBA
02/2010
1
serum P-component (CIt)
IBA
02/2010
1
3-Tyr-octreotide
IBA
09/2005
1
EDDA (NiEDDA)
IBA
09/2005
1
Camptothecin
IBA
12/2001
1
Cisplatin (Platino)
FDA Link
Generic
12/2001
1
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2001
1
Gemcitabine
FDA Link
12/2001
1
Fluorouracil (Carac)
FDA Link
Generic
12/2001
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
12/2001
1
yttrium 90-DOTA-lanreotide
IBA
06/2001
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
05/2001
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2001
1
Interferon-alpha (Interferon Alfa)
IBA
05/2001
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2001
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
03/2001
1
oxidized low density lipoprotein
IBA
02/2001
1
LDL Lipoproteins (beta Lipoproteins)
IBA
02/2001
1
LDL Receptors (LDL Receptor)
IBA
02/2001
1
Lipoprotein Receptors (Lipoprotein Receptor)
IBA
02/2001
1
Lipoproteins (Lipoprotein)
IBA
02/2001
Therapy/Procedure
11
Therapeutics
04/2019 - 01/2001
1
Intravenous Injections
02/2010
1
Drug Therapy (Chemotherapy)
02/2002
1
Intramuscular Injections
06/2000